• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prevalence and mortality prognosis of steatotic liver disease phenotypes.

作者信息

Sun Zhiyu, Zhou Chi, Zhang Yiwen, Li Pengfei, Guo Junjie, Lian Zhexun, Ji Hongwei

机构信息

Department of Cardiology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China; Qingdao Municipal Key Laboratory of Hypertension (Key Laboratory of Cardiovascular Medicine), Qingdao, Shandong, China; Chinese patient-oriented metabolic and ischemic risk evaluation (CREAT) study, Qingdao, Shandong, China.

Department of Cardiology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China; Chinese patient-oriented metabolic and ischemic risk evaluation (CREAT) study, Qingdao, Shandong, China.

出版信息

Ann Hepatol. 2024 May-Jun;29(3):101487. doi: 10.1016/j.aohep.2024.101487. Epub 2024 Feb 23.

DOI:10.1016/j.aohep.2024.101487
PMID:38403067
Abstract
摘要

相似文献

1
Prevalence and mortality prognosis of steatotic liver disease phenotypes.脂肪性肝病表型的患病率及死亡预后
Ann Hepatol. 2024 May-Jun;29(3):101487. doi: 10.1016/j.aohep.2024.101487. Epub 2024 Feb 23.
2
Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease.甘油三酯-葡萄糖相关指标与非酒精性脂肪性肝病或代谢相关脂肪性肝病患者死亡的相关性。
Cardiovasc Diabetol. 2024 Jul 4;23(1):232. doi: 10.1186/s12933-024-02343-7.
3
Reply to: Correspondence on "clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease'.回复：关于“代谢功能障碍相关脂肪性肝病和非酒精性脂肪性肝病的临床特征及死亡率相似”的通信
J Hepatol. 2024 Oct;81(4):e160-e161. doi: 10.1016/j.jhep.2024.05.024. Epub 2024 May 23.
4
[NASH (non-alcoholic steatohepatitis): fatty liver or fatal liver disease?].[非酒精性脂肪性肝炎（NASH）：脂肪肝还是致命性肝病？]
Zentralbl Chir. 2014 Apr;139(2):168-74. doi: 10.1055/s-0031-1283813. Epub 2012 Mar 22.
5
Predicting Liver-Related Outcomes in Steatotic Liver Disease.
JAMA. 2024 Apr 16;331(15):1274-1275. doi: 10.1001/jama.2024.0799.
6
Editorial: Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis: An Epidemic that will Boost the Incidence of Cardiovascular Morbidity and Mortality.社论：非酒精性脂肪性肝病和非酒精性脂肪性肝炎：一种将增加心血管疾病发病率和死亡率的流行病。
Curr Vasc Pharmacol. 2018;16(3):206-208. doi: 10.2174/157016111603180326112541.
7
Steatotic liver disease-associated all-cause/cause-specific mortality in the United States.美国脂肪变性肝病相关全因/病因特异性死亡率。
Aliment Pharmacol Ther. 2024 Jul;60(1):33-42. doi: 10.1111/apt.18011. Epub 2024 Apr 22.
8
The Association Between Liver Histology and Cardiovascular Risk: Time to Introduce Steatotic Liver Disease Screening in High-Risk Patient Groups?肝脏组织学与心血管风险之间的关联：是时候在高危患者群体中引入脂肪性肝病筛查了吗？
Angiology. 2024 Mar;75(3):205-207. doi: 10.1177/00033197231201706. Epub 2023 Sep 10.
9
[Not Available].[无可用内容]。
Ugeskr Laeger. 2024 May 6;186(19):V12230778. doi: 10.61409/V12230778.
10
Embracing Change: From Nonalcoholic Fatty Liver Disease to Metabolic Dysfunction-Associated Steatotic Liver Disease Under the Steatotic Liver Disease Umbrella.拥抱变革：在脂肪性肝病范畴下，从非酒精性脂肪性肝病到代谢功能障碍相关脂肪性肝病
Clin Gastroenterol Hepatol. 2024 Jan;22(1):9-11. doi: 10.1016/j.cgh.2023.09.034. Epub 2023 Oct 15.